From Silent Atrocities to Justice: Examining the Legal Landscape of Forced Sterilisation of Women with Disabilities across Europe
By Shivam Jadaun and Shivani,
JURISTnews
| 06. 27. 2024
Image by European Council from Flickr
In some European Union nations, the forced sterilisation of people with disabilities is still a widespread and concerning practice that blatantly violates their fundamental rights and human dignity. The scope of forced sterilisation in the EU was discovered through a study carried out by the European Disability Forum. At least 14 EU members still engage in the practice, with three of them Czechia, Hungary, and Portugal explicitly allowing it on children despite worldwide criticism and established legal frameworks which prohibits forced sterilisation such as United Nations Convention on the Rights of Persons with Disabilities, which is ratified by the EU and all its Member States, and It is also forbidden under the Council of Europe Convention on preventing and combating violence against women and domestic violence (‘Istanbul Convention’). Only nine EU nations forbid forcible sterilisation.
Moreover, The United Nations Convention on the Rights of Persons with Disabilities (“UNCRPD”), lacks explicit mention of forced sterilisation in treaty text, but the Committee on the Rights of Persons with Disabilities has gone on to emphasise protection...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...